Company: SATLW
Filing Date: 2025-03-25
Form Type: 424B3
Source: 0001437749-25-009180
Chunk: 84

Company: Satellogic Inc.
Filing Date: 2025-03-25
Form: 424B3
Chunk 84
---
, 2025) |     | $                           | 4.74 |     | $           | 2.72 |     | $            | 0.78 |     | $   | 0.33 |

On March 14, 2025, there were 88 shareholders of record of our BVI Class A Ordinary Shares, one of which was Cede & Co., a nominee for Depository Trust Company (“DTC”). On March 14, 2025, there were 4 holders of record of our BVI Warrants. All of the BVI Class A Ordinary Shares and BVI Warrants held by brokerage firms, banks and other financial institutions as nominees for beneficial owners are deposited into participant accounts at DTC and are therefore considered to be held of record by Cede & Co. as one shareholder.

<div align='center'>42

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (“MD&A”)</div>

We are incorporating by reference into this prospectus (a) the information set forth under “Item 5. Operating and Financial Review and Prospects” included in our Annual Report on Form 20-F for the fiscal year ended December 31, 2023 and (b) Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2024 included in our Report on Form 6-K furnished to the SEC on August 15, 2024. These referenced sections should be read in conjunction with the other information in this prospectus and the other information incorporated by reference into this prospectus.

Sales Agreement

On December 20, 2024, the Company entered into the Sales Agreement with the Sales Agent, pursuant to which the Company may offer and sell, from time to time, through the Sales Agent, its BVI Class A Ordinary Shares of the Company, par value $0.0001 per share, having an aggregate offering amount of up to $50,000,000. On December 20, 2024, pursuant to the Sales Agreement, the Company filed a prospectus supplement, including an accompanying base prospectus, dated December 20, 2024, forming a part of its effective registration statement on Form F-3 (File No. 333-283719), initially filed with the SEC on December 10, 2024.

On February 12, 2025, the Company entered into the Amended and Restated Sales Agreement with the